News

   

Adcendo Further Strengthens Management Team and Scientific Advisory Board with Appointment of International ADC Leaders

 Building the team with experienced biotech experts and renowned…

Synaffix Announces Expansion of Mersana License Deal to a Total Potential Value Exceeding $1 Billion

Expanded deal focuses on Synaffix’s GlycoConnect™ site-specific…

Joint Development Agreement with 4basebio PLC for novel CAR T-cell production methods

Leucid Bio: Joint Development Agreement with 4basebio PLC for…

EXACT THERAPEUTICS AS PROVIDES STRATEGIC BUSINESS UPDATE

Plans to recommence enrolment in the ACTIVATE clinical trial…

Calliditas Interim Report Q3, 2021

A quarter of deal making and regulatory review “Following…

Novo Holdings and Lundbeckfonden Portfolio Company IO Biotech Closes Initial Public Offering on the Nasdaq Global Market

Incubated and supported by Denmark’s largest biotech investors,…

Novo Holdings Co-Leads EUR 6M Seed Financing in Asgard Therapeutics

Asgard Therapeutics developing in vivo immune cell reprogramming…

Verona Pharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Enrollment in ENHANCE-1 48-week subset and ENHANCE-2 expected…

Blackstone Life Sciences to invest up to $250 million in Autolus Therapeutics to develop obe-cel in adult Acute Lymphoblastic Leukemia (ALL) and advance broader platform

LONDON, 08 November 2021: Arix Bioscience plc ("Arix", LSE:…

Arix Managing Director to Participate in Fireside Chat at the Jefferies Healthcare Conference

LONDON, 8 November 2021: Arix Bioscience plc ("Arix" or the…

Destiny Pharma’s SAB Member Professor Dale Gerding is Keynote Speaker at C. diff. International Conference

Brighton, United Kingdom – 4th November 2021 – Destiny…

Versameb to present novel data on its lead asset, VMB-100 at 9th International mRNA Health Conference

VMB-100 shows therapeutic potential in Stress Urinary Incontinence …

Phebra Acquires Equity Stake in UK Specialty Hospital Pharma Company Flexipharm Austrading

- Phebra takes part ownership of Flexipharm Austrading through…

Verona Pharma Announces November 2021 Investor Conference Participation

LONDON and RALEIGH, N.C., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Verona…

Muna Therapeutics appoints Dr. Niels Plath as Chief Scientific Officer

Brings more than 15 years of CNS drug discovery and development…

Arix Bioscience: Aura Biosciences prices Nasdaq IPO

LONDON, 29 October 2021: Arix Bioscience plc (LSE: ARIX, "Arix"),…

eTheRNA immunotherapies conference attendance for November 2021

eTheRNA immunotherapies NV (‘eTheRNA’), a private clinical-stage…

Futura Medical plc Board Appointment

Futura Medical plc (AIM: FUM), a pharmaceutical company developing…

Synendos Therapeutics Appoints Scientific Advisory Board

Synendos Therapeutics is thrilled to announce the formation of…

We’d love to hear from you.

For more information about Optimum Strategic Communications, please get in touch.

Get in touch
© Optimum Strategic Communications.